Pharmacotherapy of attention-deficit/hyperactivity disorder in adults

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 7, 1998, Pages 76-79

  Wender, Paul H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHAMPHETAMINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PEMOLINE; PEMOLINE MAGNESIUM; PHENYLALANINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TYROSINE;

ADULT; ADULT DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; SUSTAINED RELEASE PREPARATION; SYMPTOMATOLOGY;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; METHYLPHENIDATE; MONOAMINE OXIDASE; PEMOLINE; PLACEBOS; PSYCHOTHERAPY;

EID: 0031845017     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. New York, NY: Oxford University Press; 1995
2. Wainright A. Conners' Rating Scales: Over 25 Years of Research: An Annotated Bibliography. Toronto, Canada: Multi-Health Systems; 1996
3. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ('minimal brain dysfunction') in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry 1981;38:449-456
4. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890
5. Wender PH. Attention deficit hyperactivity disorder in adults: a wide view of a widespread condition. Psychiatric Annals 1997;27:556-562
6. Wender PH. Minimal brain dysfunction in children. New York, NY: John Wiley & Sons; 1971
7. Wender PH. The minimal brain dysfunction syndrome in children, I: the syndrome and its relevance for psychiatry, II: a psychological and biochemical model for the syndrome. J Nerv Ment Dis 1972;155:55-71
8. Reimherr FW, Wender PH, Ebert MH, et al. Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Res 1984;11:71-78
9. Shetty T, Chase TN. Central monoamines and hyperkinesis of childhood. Neurology 1976;26:1000-1002
10. Shaywitz BA, Cohen DJ, Bowers MB. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. J Pediatr 1977;90:67-71
11. Wood DR, Reimherr FW, Wender PH. The treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Res 1985;16:21-26
12. Reimherr FW, Wender PH, Wood DR, et al. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. Am J Psychiatry 1987;144:1071-1073
13. Wood DR, Reimherr FW, Wender PH. Effects of levodopa on attention deficit disorder, residual type. Psychiatry Res 1982;6:13-20
14. Wender PH, Wood DR, Reimherr FW, et al. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res 1983;9:329-336
15. Wood DR, Reimherr FW, Wender PH. The use of L-deprenyl in the treatment of attention deficit disorder, residual type (ADD,RT). Psychopharmacol Bull 1983;19:627-629
16. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 1976;3: 1453-1460
17. Wender PH, Reimherr FW, Wood DR, et al. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type. Am J Psychiatry 1985;142:547-552
18. Wender PH, Reimherr FW. Bupropion treatment of attention-deficit hyperactivity disorder in adults. Am J Psychiatry 1990;147:1018-1020
19. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984;41: 1059-1063
20. Spencer TJ, Wilens TE, Biederman J. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-443